Greenbrook Tms Inc

OTCQB:GBNHFUnited States

Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray), non-invasive therapies for the treatment of Major Depressive Disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The Company operates a network of outpatient mental health service centers that specialize in treatment across the United States. It offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The Company owns and operates 130 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, and Michigan.

Contact Information

Headquarters

890 Yonge St 7th FloorTORONTO, ON, Canada M4W 3P4

Phone

416-322-9700

Fax

416-322-9700

Executives

Executive Chairman of the Board

Sasha Cucuz

President, Chief Executive Officer, Director

Bill Leonard

Chief Financial Officer

Peter Willett

Chief Operating Officer

Andrew Crish

Chief Medical Officer

Geoffrey Grammer